
Medicine and Health
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
A. Goubet, A. Dubuisson, et al.
This groundbreaking research reveals that cancer patients face increased severity of COVID-19 due to altered immune responses and prolonged viral RNA detection. The study's findings suggest a complex interplay between cancer therapies and COVID-19 immunopathology. Conducted by a team of expert researchers, these insights could be pivotal in developing strategies to reduce the cancer-related death risk associated with COVID-19.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.